Stefanie Sarantopoulos, MD, PhD

Associate Professor of Medicine
Assistant Professor of Immunology
Member of the Duke Cancer Institute
Campus mail 152 Jones Bldg, Box 3961, Durham, NC 27710
Email address
In Their Words

Education and Training

  • Fellowship, Hematology/ Oncology, Dana Farber Cancer Institute, 2002 - 2005
  • Chief Resident, Internal Medicine, Boston University School of Medicine, 2001 - 2002
  • Resident, Internal Medicine, Boston University School of Medicine, 1999 - 2001
  • Intern, Internal Medicine, Boston University School of Medicine, 1998 - 1999
  • Ph.D., Boston University School of Medicine, 1998
  • M.D., Boston University, 1998


Wolff, D., H. Greinix, S. J. Lee, T. Gooley, S. Paczesny, S. Pavletic, F. Hakim, et al. “Biomarkers in chronic graft-versus-host disease: quo vadis?.” Bone Marrow Transplant 53, no. 7 (July 2018): 832–37.

Full Text

Poe, Jonathan C., Wei Jia, Hsuan Su, Sarah Anand, Jeremy J. Rose, Prasanthi V. Tata, Amy N. Suthers, et al. “An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD..” Blood 130, no. 19 (November 9, 2017): 2131–45.

Full Text

Anand, Sarah, Samantha Thomas, Kelly Corbet, Cristina Gasparetto, Gwynn D. Long, Richard Lopez, Ashley K. Morris, et al. “Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning..” In Biol Blood Marrow Transplant, 23:1949–54, 2017.

Full Text

Poe, J., J. diPaolo, W. Jia, J. Y. Kim, H. Su, N. Reyes, A. M. Marcondes, et al. “Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD).” In Bone Marrow Transplantation, 52:S46–S46. NATURE PUBLISHING GROUP, 2017.


Anand, Sarah, Samantha Thomas, Terry Hyslop, Janet Adcock, Kelly Corbet, Cristina Gasparetto, Richard Lopez, et al. “Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization..” Biol Blood Marrow Transplant 23, no. 7 (July 2017): 1151–57.

Full Text

Saliba, R. M., S. Sarantopoulos, C. L. Kitko, A. Pawarode, S. C. Goldstein, J. Magenau, A. M. Alousi, et al. “B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality..” Bone Marrow Transplantation 52, no. 7 (July 2017): 1010–15.

Full Text